Page 1

High Frequency Percussive Ventilation The Difference You Can Feel!!


Airway Clearance and Lung Rehabilitation 1 1. Compromised alveoli are swollen and filled with mucus and other debris.

2 2. Controlled, high frequency percussive pulses between 60-400 cycles per minute.

3 3. High frequency, percussive pulses and a dense aerosol mist are delivered into the lungs during therapeutic percussion, which serves to reduce the adhesive and cohesive forces of retained airway secretions.

Lung recruitment with TRUE-IPV® gently “persuades” distal airways and collapsed alveoli to open over time. This keeps the recruited lung open and functioning while atelectasis, infection, inflammation and injury are healed. 2

PHASITRON®

4

4. Healing continues with repeated TRUE-IPV® therapy sessions using the Phasitron® 5.


Improve FRC TRUE-IPV® Therapy uses the unique ® as a “clutch” mechanism PHASITRON to protect the lung from overpressure. These high frequency percussive pulses delivered by the Phasitron® 5 ramify throughout the airways and alveolar ducts and augment diffusive ventilation in the gas exchange regions of the lung, allowing improved FRC, CO2 removal, airway clearance and lung recruitment.

5 5. An improving alveolus can be a direct result of High Frequency Percussive Ventilation using the Phasitron® 5, a proven, evidence based therapy making it the safest therapy for the most fragile lungs.

TRUE-IPV®, using the PHASITRON ® , can be performed either invasively through an artificial airway or non-invasively by mouthpiece or mask. PHASITRON®

3


HFPV ventilator. Many choices.

The Percussionaire® VDR®-4 VDR®-4’s versatility delivers sub-tidal, pressure limited, time cycled, flow-interrupted breaths in biphasic (inspiratory and expiratory) oscillations that supports both diffusive and convective flow, while stacking breaths in cumulative sub-tidal volumes, air exchange, airway clearance and lung recruitment for all patient populations and can be used to treat respiratory conditions including hypoxemia, hypercapnia, aspiration, smoke inhalation and ARDS.

VDR®-4 Phasitron® Kit A50094-D-5PK

VDR®-4 with Monitron® II K00008-1

Pneumatic powered critical care ventilator using Volumetric Diffusive Respiration with pulsed flow, demand CPAP and air/O2 blender.

4

PHASITRON® CRITICAL CARE


Why rescue when you can prevent? Percussionaire® High Frequency Percussive ventilators are not just for critical care rescue. VDR®-4 brings you the safety of the Phasitron® breathing circuit to reduce barotrauma. Restoration of FRC “airway clearance”, and lung recruitment through the gentle persuasion of high frequency pulsatile flow. HFPV may be a viable less invasive alternative to ECMO if introduced early enough. CLINICAL STUDIES 2019 Wong et al, Rescue Therapy with HFPV in non-cardiac surgery patients failing Conventional Mechanical Ventilation 2018 Dutta et al, Comparison of flow and gas washout characteristics between pressure control and HFPV using a test lung 2018 Dutta et al, Comparison of pressure, volume and gas washout characteristics between PCV and HFPV in healthy and formalin fixed ex viv porcine lungs 2018 Korzhuk et al, HFPV in morbidly obese patients failing CMV 2018 Kinthala et al, Use of HFPV for Whole Lung Lavage, a case study 2018 Gulkarov et al, HFPV Facilitates weaning from ECMO in Adults 2018 Godet et al, HFPV increases alveolar recruitement in early ARDS 2017 Wong et al, HFPV in cardiac patients failing conventional mechanical ventilation 2017 Ogna et al, Prolonged Apnea Supported by High Frequency Noninvasive Ventilation 2017 Benn et al, Use of HFPV to expand organ donor pool 2015 Prior et al, Reduction of motion during PET/CT by Pulsatile Flow Ventilation 2015 Blondonnet et al, HFPV as a rescue therapy for ARDS patients under ECMO 2015 Boscolo, Peralta, Baratto, Rossi, Ori. High-frequency percussive ventilation: a new strategy for separation from extracorporeal membrane oxygenation. A&A Case Reports. 2015 Michaels et al, Protocolized use of HFPV for adults with ARDS being treated with ECMO 2014 Miller et al, Utilization of independent lung ventilation via HFPV during ECMO 2014 Reper et al, HFPV and initial biomarker levels in lung injury patients with minor burns after smoke inhalation 2014 Yehya et al, HFPV and bronchoscopy during extracorporeal life support in children 2014 Paviotti et al, HFPV as rescue treatment in severe hypoxemic respiratory failure in term neonates 2014 Spapen et al, HFPV in severe ARDS; a single center experience 2014 Ajčević et al, In vitro estimation of pressure drop across ET tube during HFPV 2014 Rizkalla N., High-frequency percussive ventilation improves oxygenation and ventilation in pediatric patients with acute respiratory failure. Journal of Critical Care. 2013 Michaels, A.J. et al., Less ECMO time for adults with H1N1 with VDR. American Journal of Surgery. 2013 Michaels et al, Reducing time on ECMO for adults with H1N1 with the use of the VDR 2012 Kunugiyama et al, HFPV using the VDR; an effective strategy for patient with Refractory Hypoxemia 2012 Feltracco et al, Non invasive HFPV in the prone position after lung transplantation 2012 Starnes-Roubaud et al, HFPV and low FiO2 2011 Barillo et al, HFPV for intercontinental aeromedical evacuation 2011 Lucangelo et al, Early short term application of HFPV Improves gas exchange in Hypoxemic patients 2011 Fitzgerald et al, Bi-caval dual lumen venovenous ECMO and HFPV support for postintubation tracheal injury and ARDS 2010 Forti et al, Haemodynamics and oxygenation improvement induced by HFPV in a patient with Hypoxia following cardiac surgery 2010 Dumas De La Roque et al, Nasal HFPV versus Nasal CPAP in transient tachypnea of the newborn: A pilot randomized control trial 2010 Lucangelo et al, Gas distribution in a two-compartment model ventilated in HFPV and Pressure controlled modes 2010 Chung et al, HFPV and low tidal volume ventilation in burns; a randomized controlled trial 2010 Dmello et al, HFPV for airway clearance in Cystic Fibrosis; a brief report 2010 Riscica et al, Portable instrument for volume measurement of high frequency percussive ventilators

Improves outcomes for patients on ECMO Ventilates patients failing other modes of ventilation Restores FRC and may reduce need for ECMO Assists with weaning from ECMO Improves Oxygenation and reduces PaCO2

PHASITRON® CRITICAL CARE

5


Bronchotron Transport Ventilator ®

The Bronchotron® Transport gives clinicians a practical and extremely portable option for High Frequency Percussive Ventilation in most patient populations. This pneumatic device can operate with a single oxygen cylinder, or from a standard high flow blender. It does not depend on electrical power and has built-in alarms and monitoring display. Display metrics: Pulse Frequency Rate, Mean Airway Pressure, Dynamic Pressure (AIP) and (AEP), Usage Timer, Pulse Amplitude Bar Graph.

Bronchotron® Transport K00038-2

Walking an ECMO patient on Bronchotron® Transport

6

BRONCHOTRON® TRANSPORT


Superior Transport Technology The unique characteristics of the Bronchotron® Transport Ventilator with the Phasitron® delivers High Frequency Percussive Ventilation via entirely pneumatic controls, which makes it suited for air or ground transport. This technology has the proven track record of safely transporting thousands of critical patients worldwide.

Transportable High Frequency Ventilation Restores FRC, may reduce need for ECMO Improves Oxygenation and reduces PaCO2 Improves airway clearance Lung recruitment Transport NICU through Bariatric patients

Image courtesy of Legacy Emanuel transport team.

Portable, compact size for easy storage Blue Band CAPLUG

Bronchotron® Transport Phasitron® Kit A50605-D-5PK

BRONCHOTRON® TRANSPORT

7


Hospital Therapy

TRUE-IPV SYSTEM ®

Designed specifically for non-continuous institutional/hospital use, these TRUE-IPV® devices provide pressure-limited, flow-interrupted, and time-cycled high frequency percussive pulses that augment diffusive ventilation in the gas exchange regions of the lung, allowing improved FRC, CO2 removal, airway clearance and lung recruitment.

IPV®-1C K00001-C

Improves airway clearance (removal of meconium) May be used non-invasively, particularly in the NICU

The IPV®-2C provides added benefits of 1. Demand CPAP 2. Inspiratory Time control 3. Inspiratory Flow control 4. On/Off Nebulization

8

PHASITRON® THERAPY

IPV®-2C K00002-C


Airway Clearance & Lung Expansion Therapy Optimized for hospital and outpatient therapeutic care bringing the benefits of TRUE-IPV速 into the ICU and NICU.

NEW

Restore FRC Improved management of exacerbations PATENT PENDING

Reduced length of stay and improved ABG

TRUE-IPV速 In-Line Valve

Used In-Line with Conventional Ventilator

Connected with

P5-10 Phasitron速 Kit Re-order Part# P5-10

P5 In-Line Valve Re-order Part# P5-TEE-20 PHASITRON速 THERAPY

9


Hospital to Home

TRUE-IPV® SYSTEM The (Impulsator®) Travel Air® allows patients to benefit from airway clearance therapy at home. Proven safe and effective, the new Travel Air® delivers the same TRUE-IPV®, using the Phasitron® 5, as the Percussionaire® hospital devices. This self-contained device is easy to use, and is suitable for adult and pediatric patients. Approved 510(k) Pending

NEW PATENT PENDING

10

PHASITRON® THERAPY

P5-TA Phasitron® Kit Re-order Part# P5-TA


Therapy for all patients Designed specifically for home care and outpatient clinics, allowing patients to benefit from airway clearance and lung rehabilitation at home. Proven safe and effective for over 30 years

TRUE-IPV®, using the Phasitron® 5, is the foremost remover of airway mucus and debris. Flow from the Phasitron® delivers pulsatile flow that gently dislodges debris and secretions to be carried out by exiting air flow.

The original home care device for Airway Clearance & Lung Expansion Therapy

P5-HC Phasitron® Re-order # P5-HC

Kit

Impulsator® K00012 Not available in the EU

P5-TH Phasitron® Re-order # P5-TH

Kit

IPV-HC® K00012-HC Not available in the EU

Lightweight portability for Airway Clearance & Lung Expansion Therapy PHASITRON® THERAPY

11


TRUE-IPV® The Difference You Can Feel!!

Right lung collapse

24 hours: Mild clearing of the right lower lobe

CLINICAL STUDIES

2019 Karashima et al, Variations in the Efficiency of Albuterol Delivery and Intrapulmonary Effects With Differential Parameter Settings on Intrapulmonary Percussive Ventilation 2018 Hughes et al, Secretion Mobilization Capabilities of Two Airway Clearance Devices 2018 Lauwers et al, The effect of intrapulmonary percussive ventilation in pediatric patients: A systematic review. 2018 Reychler et al, Intrapulmonary Percussive Ventilation as an Airway Clearance Technique in Subjects With Chronic Obstructive Airway Diseases 2018 Donizetti et al, Rapid resolution of a complete lung atelectasis using IPV®; A case report 2018 Dingmans et al, IPV® Improves lung function in CF patients chronically colonized with P. Aeruinosa; a pilot cross-over study 2018 Nicolini et al, Safety and effectiveness of of HFCWO vs IPV® in patients with severe COPD 2017 Dagan et al, A comparison of IPV® and CPT for COPD patients hospitalized for acute exacerbation 2017 Callahan et al, Utilizing IPV® in the Neonatal Population to reduce Chronic lung disease 2017 Restrepo et al, Effects of IPV® on airway mucus clearance: A bench model 2017 Fernandez-Carmona et al, Ineffective cough and mechanical mucocilliary techniques 2017 Panitch HB, Respiratory implications of pediatric neuromuscular disease 2017 Krawiec et al, IPV® as an airway clearance technique during Venoarterial Extracorporeal Life Support in an infant with Pertussus 2016 Lerg et al, IPV® as a Lung Recruitment Strategy in Brain-dead organ donors 2016 Arcuri et al, Benefits of interventions for respiratory secretion mangement in adult palliative care patients - a systematic review 2016 Van Ginderdeuren et al, Effectiveness of airway clearance techniques in children hospitalized with acute bronchiolitis 2016 Spapen et al, Intrapulmonary Percussion with autogenic drainage and ventilator-associated Gram-negative infection: A pilot study 2016 Van Ginderdeuren et al, Influence of IPV® in upright position on gastro-oesophageal reflux in infants 2014 Testa el al Efficacy of short-term IPV® in patients with COPD Distributor 2013 Riffard et al, IPV® Superimposed to conventional mechanical ventilation: comparison between Volume controlled and Pressure controlled mode. A Bench study 2013 Andrews et al Fornasa et al, Airway clearance techniques in hospital patients

48 hours: Re-expansion continues

72 hours: Improvement/ recruitment continues

TRUE-IPV® P20055 Rev A

The information and images in this brochure are subject to change without notice.

M 130 McGhee Road, Suite 109, Sandpoint ID 83864 percussionaire.com 208.263.2549

Profile for Percussionaire

Percussionaire 2019 Brochure- United States  

Percussionaire 2019 Brochure- United States